Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2463${count})

  • MJFF Research Grant, 2009
    Gastrointestinal Function in Parkinson's Mice

    Promising Outcomes of Original Grant:
    Our original project was designed to screen several well-known models of Parkinson’s disease to determine if any mimic the gastrointestinal symptoms (constipation...

  • Program-non-specific Funding, 2009
    Analysis of Adhesion and Chemotactic Factor Expression Possibly Involved in T Cell Brain Extravasation in Parkinsonism: Preliminary Studies for a Target Validation

    Promising Outcomes of Original Grant:
    In a previous study funded by The Michael J. Fox Foundation, we have provided compelling evidence that brain infiltration of peripheral immune cells (in particular...

  • Target Validation, 2009
    Testing PDE-1 Inhibitor in MPTP-treated Macaques

    Promising Outcomes of Original Grant:
    Our goal is to develop novel therapeutic molecules that promote normal dopamine neurotransmission in the brain affected by PD. We hypothesize that these molecules...

  • MJFF Research Grant, 2009
    Investigating Placebo Effects in Parkinson's Disease with Functional MRI

    Objective/Rationale:
    Many researchers believe that placebo treatments may have beneficial effects on symptom progression in Parkinson’s disease, but there is very little experimental evidence on...

  • MJFF Research Grant, 2009
    The Validation of Anxiety Scales in Parkinson's Disease

    Objective/Rationale:
    This study has two objectives:
    1. To assess the occurrence and symptoms of anxiety disorders in Parkinson's disease, including atypical anxiety syndromes, and anxiety states...

  • Novel Approaches to Drug Discovery for Parkinson's Disease, 2009
    Inhibition of Brain-Dependent Nitric Oxide (NO) Over-Production by Isoform-Selective NO Synthase (NOS) Inhibitors

    Objective/Rationale: 
    The project objective is to test whether custom-designed, small-molecule, isoform-selective NOS inhibitors can reduce brain and systemic nitric oxide levels and show improved...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.